Helen Won
0000-0001-5237-7529
4 papers found
Refreshing results…
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Missing publications? Search for publications with a matching author name.